arrow
S

Sebastian M. Dieter

Helmholtz Association
H指数:15
被引数:1,366

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Primary results from TACTI-003: A randomized phase IIb trial comparing eftilagimod alpha (soluble LAG-3) plus pembrolizumab versus pembrolizumab alone in first-line recurrent or metastatic head and neck squamous cell carcinoma with CPS ≥1

TACTI-003试验的初步结果:一项随机IIb期临床试验,比较eftilagimod alpha(可溶性LAG-3)联合pembrolizumab与单独使用pembrolizumab治疗CPS ≥1的初治复发或转移性头颈部鳞状细胞癌。

2024-09-010
PRE
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer

CCNK/CDK12的降解是结直肠癌的药物脆弱性

2021-07-0150
OAAI
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
2021-01-2916
OAAI
A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells

骨髓中的血管周围生态位宿主静止和增殖的致瘤性结直肠癌细胞

2020-03-047
OAAI
Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer
CELLS
IF5.2
2019-02-1012
OAAI
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer
2017-06-0127
OAAI
Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts
2017-05-1936
OAAI
Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation
2017-01-2724
OAAI
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma
2017-01-0114
OAAI
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking
2016-11-21320
OAAI
Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells

表型分化不影响原代人结肠癌起始细胞的致瘤性

2016-02-0111
PRE